VDV.O. Dzisiak

V.O. Dzisiak

*This is an algorithmically generated author record based on publicly available information.

V.O. Dzisiak has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serum club cell secretory protein 16 levels in children with asthma: a prospective observational study

    by V.O. Dzisiak, Y.H. Antypkin, T.R. Umanets, T.A. Harashenko, Y.M. Bondarenko, D.V. Zabara, Y.I. Anoshko

    Background. Sustained asthma control in children is often difficult to achieve, and biomarkers reflecting airway epithelial integrity are needed. Club cell secretory protein 16 (CC16) is a candidate marker of epithelial injury and lower airway inflammation. Objective: to determine serum CC16 in children with asthma according to disease severity and control. Materials and methods. This prospective study enrolled 72 children aged 6–17 years: 52 with asthma (mild, n = 13; moderate, n = 22; severe, n = 17) and 20 healthy controls. Serum CC16 was measured by enzyme-linked immunosorbent assay, and asthma control was assessed with the Childhood Asthma Control Test. Data are presented as mean ± SEM; a multivariable model assessed the association between CC16 and asthma severity, adjusted for confounders including age and sex. Results. Children with asthma had markedly lower serum CC16 concentrations than controls (1.80 ± 0.16 vs 2.51 ± 0.15 ng/mL; p = 0.0001). CC16 showed an inverse correlation with asthma severity (r = –0.45; p < 0.001). In children with mild asthma, the mean CC16 level was 2.42 ± 0.56 ng/mL and was notably higher than in severe asthma, where the lowest values were recorded (1.20 ± 0.06 ng/mL; p = 0.024). In moderate asthma, the mean CC16 concentration was 1.90 ± 0.14 ng/mL and was also lower than in the control group (p = 0.006). No statistically significant differences were found according to asthma control status (p = 0.148), although a downward trend in CC16 concentration was observed with poorer disease control. Mean CC16 decreased across control categories: 2.32 ± 0.43 ng/mL in controlled, 1.56 ± 0.11 ng/mL in partially controlled, and 0.85 ± 0.02 ng/mL in uncontrolled asthma. In the multivariable model, asthma severity remained an independent predictor of serum CC16 (β = –0.73; p = 0.002). Conclusions. In children with asthma, serum CC16 is reduced in proportion to disease severity, with the lowest levels in severe asthma, supporting its potential as a non-invasive biomarker of disease course.

  • Features of sensitization and clinical course of atopic dermatitis in children during the war in Ukraine

    by T.R. Umanets, A.A. Buratynska, V.O. Dzisiak, L.S. Stepanova, V.F. Lapshyn, O.V. Surmasheva, Y.G. Antipkin, L.O. Turova

    Atopic dermatitis (AD) is the most common chronic inflammatory skin disease, which affects 15% to 20% of children and 5% to 20% of adolescents. One of the key factors influencing the clinical course of AD and the further prognosis of the disease in children is sensitization to allergens, which can be specific trigger factors. War conditions impose significant additional risks regarding the development of sensitization and the severity of the disease. Aim - to investigate the features of the clinical course and sensitization profile in children with AD during the war in Ukraine. Materials and methods. A retrospective analysis of medical records of 62 children aged 5-17 years with a diagnosis of AD was conducted. Children were divided into two groups: before the war (group I, n=30), and after its onset (group II, n=32). The following parameters were analyzed: gender, age, severity of AD, sensitization profile, presence of concomitant diseases. Results. Among the patients in group II, a significant decrease in the number of children with mild AD was observed, along with a tendency toward an increase in patients with moderate-severe disease (20.0% versus 40.62%). Furthermore, concomitant bronchial asthma was significantly more prevalent in this group (20.0% versus 52.0%). Sensitization to common allergens was determined in both groups with a tendency to an increase in sensitization to «internal» aeroallergens (house dust mites and mold) in children of group II, which was associated with the established unsatisfactory condition of bomb shelters. Conclusions. The results indicate a deterioration in the course of AD in children during the war in Ukraine, an increase in cases of AD with concomitant asthma, an increase in the frequency of sensitization to aeroallergens of the «indoor environment», which may be associated with the unsatisfactory condition of bomb shelters. The obtained data indicate the need for further scientific research on the study of risk factors associated with the war in Ukraine. The study was performed in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Local Ethics Committee of the institution mentioned in the work. Informed consent of the patients was obtained for the research. The authors declare no conflict of interest.

  • Open Access

    Бронхіальна астма у дітей через призму сучасності

    by А. А. Буратинська, В. О. Дзісяк, Т. А. Гаращенко

    Мета. Огляд сучасних даних щодо поширеності, факторів ризику, генетичних та епігенетичних чинників, особливостей патогенезу та перебігу, підходів до діагностики та лікування бронхіальної астми у дітей. Бронхіальна астма (БА) у дітей є одним із 20 найпоширеніших хронічних захворювань у світі, які призводять до інвалідності. За останні роки поширеність БА у дітей має тенденцію до зростання і складає до 20 % дітей в залежності від географічного регіону. Фактори навколишнього середовища, генетична схильність, кесарів розтин, надмірна вага при народженні, забруднене повітря і пасивне куріння сприяють розвитку БА. У формуванні БА у дітей мають значення механізми пов’язані з алерген-специфічними IgE та неалергічні і, які можуть співіснувати. Виділяють «вірусіндукований» фенотип, «алергеніндукований» фенотип, фенотип «індукований фізичним навантаженням» та «астму з ожирінням». У дітей з БА найчастіше зустрічається алергічний фенотип БА (у 85 % дітей з БА), який пов’язаний з наявністю сенсибілізації до алергенів та опосередкований Т-хелперами типу 2. Клінічна картина БА характеризується наявністю хрипів, кашлю, стиснення в грудях, утрудненого дихання. Встановлення діагнозу БА потребує збір анамнестичних даних, проведення клінічних та інструментальних методів обстеження. Мета лікування БА полягає в досягненні контролю над симптомами з використанням мінімальної дози лікарських засобів з переважним застосуванням препаратів, що містять інгаляційні кортикостероїди. Для дітей до 6 років використовується чотири кроковий підхід покрокової терапії БА, а з 6 років – п’яти кроковий підхід рекомендацій та дозування медикаментозних препаратів залежно від ступеню тяжкості та контролю БА.


  • Open Access

    Алергічний риніт як «бар’єрне» захворювання респіраторного епітелію: роль топічного ектоїну

    by Т. Р. Уманець, Т. А. Гаращенко, А. А. Буратинська, В. О. Дзісяк

    Резюме. Мета – проаналізувати сучасні дані щодо «епітеліальної барʼєрної гіпотези» в генезі алергічного риніту, а також роль ектоїну в лікуванні даної патології. Алергічний риніт (АР) є найпоширенішим IgE-опосередкованим запальним захворюванням слизової оболонки носа внаслідок дії алергенів та залишається серйозною соціальною і економічною проблемою у світі. Сучасні дослідження свідчать про наявне порушення епітеліальної бар’єрної функції та підвищення проникності респіраторного епітелію для алергенів та патогенів у пацієнтів з АР. Дефекти респіраторного бар'єру є результатом численних екзогенних та ендогенних тригерів, які порушують цілісність епітелію, сприяючи розвитку АР. Порушення бар’єрної функції респіраторного епітелію призводить до розвитку частих вірусних захворювань як важливого тригерного фактору загострення алергічного запалення, особливо у дітей. Останніми роками збільшується зацікавленість у використанні альтернативних і додаткових засобів для кращого контролю симптомів та полегшення стану пацієнтів з АР. Одним із таких немедикаментозних засобів є ектоїн. Клінічні дослідження свідчать, що ектоїн не лише полегшує симптоми АР, але й зміцнює бар’єрну функцію слизової оболонки, що сприяє її захисту від алергенів, інфекційних агентів та забруднюючих речовин.

  • Open Access

    Modern approaches to diagnosis and treatment of respiratory epithelial dysfunction

    by Kyiv Si Ukrainian Center Of Maternity And Childhood Of The Nams Of Ukraine, T.R. Umanets, V.O. Dzisiak, A.A. Buratynska, T.A. Harashchenko, Yu.M. Bondarenko

    The integrity of the respiratory epithelium protects the airways from the penetration of external harmful agents. Impairments in the structure and function of the epithelial barrier can lead to chronic inflammatory processes that underlie the pathogenesis of numerous allergic and inflammatory respiratory diseases, particularly in children. Аim - to review contemporary scientific literature on the role of epithelial barrier dysfunction in the development of allergic diseases, and to examine methods for the diagnosis and treatment of respiratory epithelial dysfunction (RED) based on the latest scientific evidence. An analysis of literature from international databases, including PubMed, ScienceDirect, and Google Scholar, for the period 2018-2025 was conducted. RED involves the disruption of its structural integrity, leading to a compromised barrier function and increased permeability to external agents such as allergens, pollutants, and pathogens. In patients with asthma, a decreased expression of proteins that form tight junctions between epithelial cells is observed, constituting a critical pathogenetic mechanism in the development of respiratory allergic diseases. The combined use of modern methods—such as histological and immunohistochemical analyses, electron microscopy, mass spectrometry, proteomics, and the study of alarmins — allows for a more effective assessment of the respiratory epithelial barrier's status. Modern therapeutic strategies for RED are aimed at restoring the structure and function of epithelial tight junctions. Conclusions. RED is a key factor in the development of asthma and other respiratory diseases, especially in the pediatric population. Early diagnosis and timely intervention to enhance epithelial barrier function are critical for achieving successful disease control. Future research prospects include the development of novel preventive and therapeutic approaches aimed at restoring and maintaining the integrity of the respiratory epithelium. The authors declare no conflict of interest.


  • Open Access

    Efficacy and tolerability of basic treatment with montelukast and fluticasone propionate in school-age children with asthma combined with allergic rhinitis

    by Kyiv Si Ukrainian Center Of Maternity And Childhood Of The Nams Of Ukraine, T.R. Umanets, A.A. Buratynska, V.O. Dzisiak

    Conducting post-marketing studies to study the effectiveness and safety of the use of leukotriene antagonists, in particular montelukast, in alternative treatment regimens for children with comorbid asthma remains important for personalized therapy. Aim - to study the effectiveness and tolerability of basic therapy with the use of montelukast 5 mg and fluticasone propionate 125 mcg in children with comorbid mild asthma and comorbid moderate asthma, combined with mild persistent allergic rhinitis (AR). Materials and methods. The clinical effectiveness and tolerability of two basic treatment regimens were prospectively analyzed: montelukast 5 mg monotherapy (group I, n=28, patients with mild asthma and RA) and combined use with fluticasone propionate 125 mcg per day (group II, n=20, patients with moderate asthma and mild persistent AR) for 12 weeks in children aged 6-11 years. The controllability of asthma symptoms was assessed using the validated Children's Asthma Control Test (C-AСT) questionnaire, and the symptoms of asthma were assessed using the visual analog scale (VAS). Results. Basic therapy with the use of montelukast had a positive effect on the controllability of asthma and AR symptoms in the both groups of children, which was evidenced by a probable (p=0.000) increase in the C-AСT test index with a higher score in children of the II group (p=0.006). Against the background of treatment, the total VAS index in children of the groups I and II decreased by 2.8 times. Monitoring of adverse events against the background of treatment in the studied groups of children testified to the good tolerability of the applied treatment regimens. Only 1 (3.6%) child of the group I had minor abdominal pain. Conclusions. Monotherapy with montelukast and combined use with fluticasone propionate effectively controls the symptoms of mild and moderate asthma combined with mild persistent RA in children, and is well tolerated. The study was carried out in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Committee on bioethics and deontology of these institutions. The informed consent of the children's parents was obtained for the research. No conflict of interests was declared by the authors.

  • Open Access

    Characteristics of bronchial asthma in children during the war in Ukraine

    by Kyiv Si Ukrainian Center Of Maternity And Childhood Of The Nams Of Ukraine, V.O. Dzisiak, T.R. Umanets, Yu.G. Antypkin

    Aim - to study the features of the course of bronchial asthma (BA) in children during the war in Ukraine. Materials and methods. A retrospective analysis of medical records was conducted for 145 children aged 5-17 years diagnosed with BA of varying severity from 2014 to May 2024. All children were divided into two groups: before the start of the war (Group I, n=72) and after the start of the war (Group II, n=73). The following parameters were analyzed: gender, age, BA phenotype, severity of BA, level of BA control, number of exacerbations per year, sensitization profile, basic therapy, and presence of comorbidities. Results. Among the children in the Group II, there was a significantly higher frequency of severe BA cases (23% compared to 11%), with corresponding basic therapy using inhaled corticosteroids and long-acting beta-agonists (ICS/LABA) (30% compared to 14%), an increased number of patients with the mixed phenotype (60% compared to 44%) and comorbid BA (97% compared to 86%), as well as patients sensitized to more than 7 allergens (11% compared to 0%). Conclusions. The study results demonstrated a worsening of the course of BA in children during the war in Ukraine, which may be associated with psycho-emotional stress, delayed access to medical care, and the negative impact of environmental pollution. This necessitates further scientific research to study the risk factors related to the war in Ukraine. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of participating institution. The informed consent of the patient was obtained for conducting the studies. No conflict of interest was declared by the authors.

  • Open Access

    To the question of the rare children’s diseases which manifests as fever and somatic pain. Clinical case

    by O.A. Oshlyanska, T.G. Nadtochiy, V.O. Dzisiak

    Neuroblastoma is one of the most common tumor in the pediatric population, with the frequent localization in the retroperitoneal space. In the early stages disease can be asymptomatic and complicates diagnostic. The initial manifestations are not specific and can be considered as symptoms of different diseases. Purpose - to analyze and note some "red flags" of certain rare diseases that allow to suspect these diseases in children with fever and somatic pain. The article presents the data and clinical observation of a child with neuroblastoma with rapid progressive development and rapid metastasis. The features of the course and complications of the primary differential diagnosis of a malignant tumor process are described in a 3-year-old boy. The child was taken to the SI «Institute of Pediatrics, Obstetrics and Gynecology named of academician O.M. Lukyanova NAMS of Ukraine» with complaints of back pain, refusal to walk, weight loss and fever. The child was transferred to the intensive care unit for hemotransfusion due to progressive negative dynamics of the condition (pronounced pain syndrome, intoxication syndrome, oliguria). After demonstration an improvement the boy with the diagnosis of «Retroperitoneal neoplasm (neuroblastoma?), neoplasm of the left hand, neoplasm of the sternum; severe anemia of complex genesis; pathological compression fractures of vertebral bodies Th3, Th10, Th12 and L2; secondary hypoparathyroidism; functional bowel disorder; moderate degree of hypermetropia, strabismus, partial atrophy of the optic nerve» was transferred to the National Cancer Institute in the department of pediatric oncology for further examination and determination of the tactics of further therapy, where MRI of the brain and spinal cord with contrast, SCT of the head, chest, abdomen, pelvis, and bone biopsy were performed. This case will help pediatricians to suspect the presence of a tumor in the early stages and refer them to specialized specialists for the further examination as early as possible. The research was carried out in accordance with the principles of the Helsinki Declaration. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.